New injection could help shed pounds in obesity trial
NCT ID NCT06728124
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This Phase 3 study tests an injection called GZR18 for weight loss in 630 adults who are obese or overweight with related health issues. Participants receive either the drug or a placebo, and researchers measure weight change over time. The goal is to see if GZR18 is safe and effective for helping people lose weight.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GZR18 injection
What this could lead to
If successful, this could provide a new medication option for significant weight loss in people with obesity or overweight.
What could go wrong
This is a Phase 3 trial, but results are not yet published. The drug may cause side effects or not work better than placebo. Long-term safety and effectiveness are still unknown.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- GLP-1 Drugs and Alzheimer's Prevention Study (NCT07677865)
- Cooking Classes for Weight Management in Abu Dha NCT07675148
- TIX100 Safety Trial for Overweight/Obesity (NCT07675590)
- Time-Restricted Eating After Bariatric Surgery – NCT07672821
- Spermidine for Weight & Cholesterol Trial NCT07662330
- UBT251 for Weight Loss in Obesity Trial (NCT07648225)
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing
Beijing, China